Stevens Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270K | Buy |
+1,232
| New | +$270K | 0.07% | 192 |
|
|
2024
Q4 | – | Sell |
-812
| Closed | -$244K | – | 389 |
|
|
2024
Q3 | $244K | Buy |
+812
| New | +$244K | 0.03% | 178 |
|
|
2024
Q1 | – | Sell |
-5,546
| Closed | -$1.95M | – | 369 |
|
|
2023
Q4 | $1.95M | Buy |
+5,546
| New | +$1.95M | 0.49% | 40 |
|
|
2023
Q3 | – | Sell |
-953
| Closed | -$364K | – | 350 |
|
|
2023
Q2 | $364K | Sell |
953
-383
| -29% | -$146K | 0.07% | 203 |
|
|
2023
Q1 | $463K | Sell |
1,336
-23
| -2% | -$7.97K | 0.11% | 120 |
|
|
2022
Q4 | $320K | Sell |
1,359
-27
| -2% | -$6.36K | 0.2% | 83 |
|
|
2022
Q3 | $341K | Buy |
+1,386
| New | +$341K | 0.22% | 90 |
|
|
2022
Q2 | – | Sell |
-809
| Closed | -$332K | – | 260 |
|
|
2022
Q1 | $332K | Sell |
809
-1,848
| -70% | -$758K | 0.07% | 200 |
|
|
2021
Q4 | $1.25M | Buy |
2,657
+2,133
| +407% | +$1M | 0.29% | 92 |
|
|
2021
Q3 | $222K | Buy |
+524
| New | +$222K | 0.09% | 155 |
|
|
2018
Q1 | – | Sell |
-24,576
| Closed | -$2.43M | – | 1021 |
|
|
2017
Q4 | $2.43M | Buy |
24,576
+14,740
| +150% | +$1.45M | 0.09% | 262 |
|
|
2017
Q3 | $947K | Buy |
+9,836
| New | +$947K | 0.04% | 441 |
|
|
2016
Q4 | – | Sell |
-9,619
| Closed | -$717K | – | 1144 |
|
|
2016
Q3 | $717K | Sell |
9,619
-2,891
| -23% | -$215K | 0.03% | 498 |
|
|
2016
Q2 | $949K | Buy |
+12,510
| New | +$949K | 0.04% | 428 |
|
|
2016
Q1 | – | Sell |
-8,265
| Closed | -$498K | – | 1141 |
|
|
2015
Q4 | $498K | Sell |
8,265
-12,239
| -60% | -$737K | 0.02% | 565 |
|
|
2015
Q3 | $1.11M | Buy |
+20,504
| New | +$1.11M | 0.05% | 332 |
|
|
2015
Q1 | – | Sell |
-10,658
| Closed | -$567K | – | 1271 |
|
|
2014
Q4 | $567K | Buy |
+10,658
| New | +$567K | 0.02% | 548 |
|
|
2014
Q3 | – | Sell |
-20,522
| Closed | -$866K | – | 1282 |
|
|
2014
Q2 | $866K | Buy |
20,522
+4,030
| +24% | +$170K | 0.02% | 529 |
|
|
2014
Q1 | $726K | Buy |
+16,492
| New | +$726K | 0.02% | 557 |
|